Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient

• Hoofdauteurs: Qiang Ma (Auteur), Yixian Guo (Auteur), Xiaoxi Lan (Auteur), Guoxiang Wang (Auteur), Wanling Sun (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2021-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Somatic mutations in Wilms' tumor 1 (WT1) and tet methylcytosine dioxygenase 2 (TET2) genes were separately perceived as contributors to hematopoietic disorders and usually thought to have a mutually exclusive effect in acute myeloid leukemia (AML). However, we found novel W...